Mode
Text Size
Log in / Sign up

Review suggests acupuncture may target cell death pathways in Parkinson's diseaseCould acupuncture protect brain cells in Parkinson's disease?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider mechanistic review findings on acupuncture for PD as theoretical; clinical efficacy and safety are not established.

A systematic review explored the role of programmed cell death (PCD) mechanisms—including autophagy, apoptosis, pyroptosis, necroptosis, and ferroptosis—in the pathogenesis of Parkinson's disease (PD). The review describes how these pathways interact through neuroinflammation, mitochondrial dysfunction, and oxidative stress to drive dopaminergic neuron death and α-synuclein aggregation.

The review also examined acupuncture as a potential intervention for PD. It concludes that acupuncture shows beneficial effects by targeting multiple PCD pathways. However, no specific effect sizes, absolute numbers, p-values, or confidence intervals were reported for this finding. The comparator, population, sample size, and follow-up duration were not reported.

No safety, tolerability, or adverse event data were reported. The review did not report its funding sources or potential conflicts of interest. A key limitation is that this is a review article summarizing existing evidence; it does not present new primary clinical trial data. The practice relevance is therefore theoretical, describing a mechanistic rationale rather than demonstrating clinical efficacy. Clinicians should interpret these findings cautiously as they represent an association reported in the literature without quantification of benefit or risk.

What if a traditional therapy could slow the brain cell loss at the heart of Parkinson's disease? A fresh look at the science suggests acupuncture might do just that by influencing several forms of programmed cell death—the natural processes that go haywire and destroy dopamine-producing neurons in the condition. The review found that these cell death pathways are deeply interconnected through inflammation and cellular stress, and that acupuncture appears to have a beneficial effect on them. It's important to understand this is a review paper, not a new clinical trial. The authors are piecing together existing evidence to propose a biological story for how acupuncture might work. We don't have numbers on how much it might help people, what the side effects could be, or how it stacks up against other treatments. The finding is a promising clue about a potential mechanism, not proof of a cure.

What this means for you:
Acupuncture may target cell death in Parkinson's, but clinical benefits are still unknown.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
As the population ages, Parkinson’s disease (PD) has become a prevalent neurodegenerative disorder, posing a significant threat to the health and quality of life of the elderly. The core pathological features include progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the formation of Lewy bodies, which result from aberrant aggregation of α-synuclein (α-syn). The pathogenesis of PD involves multi-level, cross-system cellular mechanisms. Recent evidence reveals that classical forms of programmed cell death (PCD)—including autophagy, apoptosis, pyroptosis, necroptosis, and ferroptosis—interact through key nodes such as neuroinflammation, mitochondrial dysfunction, and oxidative stress. This interplay drives dopaminergic neuron death and α-syn aggregation, thereby accelerating PD progression. Acupuncture has emerged as a prominent non-pharmacological therapeutic strategy for PD, showing beneficial effects by targeting multiple PCD pathways. This review systematically delineates the roles of autophagy, apoptosis, pyroptosis, necroptosis, and ferroptosis in PD pathogenesis. Furthermore, it identifies key molecular mediators and physiological outcomes through which acupuncture ameliorates PD by regulating PCD-related signaling, thereby providing a mechanistic rationale for the development of targeted interventions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.